Home Ovarian and uterine leiomyosarcoma: which one is the primary?
Article
Licensed
Unlicensed Requires Authentication

Ovarian and uterine leiomyosarcoma: which one is the primary?

  • Mohamad Nasir Shafiee , Chew Kah Teik EMAIL logo , Reena Rahayu Md Zain and Nirmala Kampan
Published/Copyright: August 9, 2019

Abstract

Uterine leiomyosarcoma (LMS) is rare but primary ovarian LMS is even rarer constituting less than 0.1% of all gynecologic disorders. Neither histologic features nor immunohistochemistry could be utilized to distinguish between uterine or ovarian origin. We illustrate a clinical case of metastatic LMS to the ovary in a woman with underlying uterine fibroid presenting with anemia with heavy menses.

Author statement

  1. Research funding: None declared.

  2. Conflict of interest: None declared.

  3. Informed consent: Not applicable.

  4. Ethical approval: Not applicable.

References

[1] Tirumani SH, Deaver P, Shinagare AB, Tirumani H, Hornick JL, George S, et al. Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients. J Gynecol Oncol. 2014;25:306–12.10.3802/jgo.2014.25.4.306Search in Google Scholar PubMed PubMed Central

[2] Bouie SM, Cracchiolo B, Heller D. Epithelioid leiomyosarcoma of the ovary. Gynecol Oncol. 2005;97:697–9.10.1016/j.ygyno.2005.02.008Search in Google Scholar PubMed

[3] Anderson B, Turner DA, Benda J. Ovarian sarcoma. Gynecol Oncol. 1987;26:183–92.10.1016/0090-8258(87)90272-1Search in Google Scholar PubMed

[4] Dandapani M, Seagle B-LL, Abdullah A, Hatfield B, Samuelson R, Shahabi S. Metastatic uterine Leiomyosarcoma involving bilateral ovarian Stroma without capsular involvement implies a local route of Hematogenous dissemination. Case Rep Obstet Gynecol. 2015;2015.10.1155/2015/950373Search in Google Scholar PubMed PubMed Central

[5] Lakhman Y, Veeraraghavan H, Chaim J, Feier D, Goldman DA, Moskowitz CS, et al. Differentiation of uterine leiomyosarcoma from atypical leiomyoma: diagnostic accuracy of qualitative MR imaging features and feasibility of texture analysis. Eur Radiol. 2017;27:2903–15.10.1007/s00330-016-4623-9Search in Google Scholar PubMed PubMed Central

[6] Chiang S, Oliva E. Recent developments in uterine mesenchymal neoplasms. Histopathology. 2013;62:124–37.10.1111/his.12048Search in Google Scholar PubMed

[7] Hensley ML, Barrette BA, Baumann K, Gaffney D, Hamilton AL, Kim J-W, et al. GCIG Consensus review: uterine and ovarian leiomyosarcomas. Int J Gynecol Cancer: J Int Gynecol Cancer Soc. 2014;24(9 Suppl 3):S61.10.1097/IGC.0000000000000261Search in Google Scholar PubMed PubMed Central

[8] Roberts ME, Aynardi JT, Chu CS. Uterine leiomyosarcoma: a review of the literature and update on management options. Gynecol Oncol. 2018;151(3):562–72.10.1016/j.ygyno.2018.09.010Search in Google Scholar PubMed

[9] Pautier P, Floquet A, Gladieff L, Bompas E, Ray-Coquard I, Piperno-Neumann S, et al. A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group. Ann Oncol. 2012;24:1099–104.10.1093/annonc/mds545Search in Google Scholar PubMed

[10] van der Graaf WT, Blay J-Y, Chawla SP, Kim D-W, Bui-Nguyen B, Casali PG, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet. 2012;379:1879–86.10.1016/S0140-6736(12)60651-5Search in Google Scholar PubMed

Received: 2019-07-02
Accepted: 2019-07-12
Published Online: 2019-08-09

© 2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Letters to the Editor
  2. Androgen-driven COVID-19 infection – is testosterone an enemy or a friend?
  3. Tumor necrosis factor-α gene-1031T/C promoter polymorphism and endometriosis
  4. Original Articles
  5. Serum FGF-21 and FGF-23 in association with gestational diabetes: a longitudinal case-control study
  6. Neutrophil and monocyte ratios to high-density lipoprotein-cholesterol and adiponectin as biomarkers of nascent metabolic syndrome
  7. Predicting long-term cardiovascular outcomes of patients with acute myocardial infarction using soluble ST2
  8. Anti-inflammatory activity of emu oil-based nanofibrous scaffold through downregulation of IL-1, IL-6, and TNF-α pro-inflammatory cytokines
  9. A comparative study of the antidiabetic effect of two training protocols in streptozotocin-nicotinamide diabetic rats
  10. Gonadotrophins modulate cell death-related genes expression in human endometrium
  11. Exploring the activity of the enzyme 11β-hydroxylase in the polycystic ovary syndrome
  12. The effects of follicle-stimulating hormone receptor (FSHR) -29 and Ser680Asn polymorphisms in IVF/ICSI
  13. Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples
  14. Investigation of the role of β-TrCP in growth hormone transduction defect (GHTD)
  15. High-intensity interval training with long duration intervals is more effective than short duration intervals for improving glycolytic capacity in the rats’ gastrocnemius muscle
  16. The effects of circuit resistance training on plasma progranulin level, insulin resistance and body composition in obese men
  17. Sexual motivation: problem solved and new problems introduced
  18. Case Reports
  19. Ovarian and uterine leiomyosarcoma: which one is the primary?
  20. Uterine-conserving approach in ruptured intramyometrial ectopic pregnancy
Downloaded on 6.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/hmbci-2019-0037/html
Scroll to top button